UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Preferences of Canadian patients and physicians for adjuvant treatments for melanoma

Current oncology (Toronto), 2019-12, Vol.26 (6), p.e755-765

2019

Volltextzugriff (PDF)

Cost-effectiveness of pazopanib compared with sunitinib in metastatic renal cell carcinoma in Canada

Current oncology (Toronto), 2016-08, Vol.23 (4), p.e340-354

2016

Volltextzugriff (PDF)

Healthcare utilization and costs associated with skeletal-related events in prostate cancer patients with bone metastases

Prostate cancer and prostatic diseases, 2013-03, Vol.16 (1), p.23-27

2013

Volltextzugriff (PDF)

Association between treatment effects on disease progression end points and overall survival in clinical studies of patients with metastatic renal cell carcinoma

British journal of cancer, 2012-09, Vol.107 (7), p.1059-1068

2012

Volltextzugriff (PDF)

Cost-effectiveness of lapatinib plus letrozole in her2-positive, hormone receptor-positive metastatic breast cancer in Canada

Current oncology (Toronto), 2013-10, Vol.20 (5), p.e371-387

2013

Volltextzugriff (PDF)

The Cost of Treatment of Skeletal-Related Events in Patients with Bone Metastases from Lung Cancer

Oncology, 2004-01, Vol.67 (5-6), p.390-396

2004

Volltextzugriff (PDF)

Cost-effectiveness of pazopanib in advanced soft-tissue sarcoma in Canada

Current oncology (Toronto), 2014-12, Vol.21 (6), p.e748-759

2014

Volltextzugriff (PDF)

1353P Prediction of the risk of recurrence in patients with non-small cell lung cancer using an integrated claims and electronic medical record database

Annals of oncology, 2022-09, Vol.33, p.S1157-S1158

2022

Volltextzugriff (PDF)

Cost-effectiveness of zoledronic acid compared with clodronate in multiple myeloma

Current oncology (Toronto), 2012-12, Vol.19 (6), p.e392-403

2012

Volltextzugriff (PDF)

Conclusions regarding relative cost–utility of alternative strategies for use of aromatase inhibitors in postmenopausal women with early breast cancer are premature

Annals of oncology, 2007-01, Vol.18 (1), p.197-198

2007

Volltextzugriff (PDF)

The Causal Role for Genital Ulcer Disease as a Risk Factor for Transmission of Human Immunodeficiency Virus: An Application of the Bradford Hill Criteria

Sexually transmitted diseases, 1996-09, Vol.23 (5), p.429-440

1996

Volltextzugriff (PDF)

Cost effectiveness of carvedilol for heart failure

The American journal of cardiology, 1999-03, Vol.83 (6), p.890-896

1999

Volltextzugriff (PDF)

POSC34 Comparative Efficacy and Safety of Isatuximab Plus Pomalidomide and Dexamethasone Versus Daratumumab Plus Pomalidomide and Dexamethasone in Patients with Multiple Myeloma Using a Matching-Adjusted Indirect Comparison

Value in health, 2022-01, Vol.25 (1), p.S39-S39

2022

Volltextzugriff (PDF)

2.212 Improved adherence to levodopa/carbidopa/entacapone (Stalevo®) or levodopa/carbidopa and entacapone as separate tablets reduces medical care utilization and costs among Parkinson's disease patients

Parkinsonism & related disorders, 2007, Vol.13, p.S100-S101

2007

Volltextzugriff (PDF)

163P Population-adjusted comparison of SOLAR-1 and BOLERO-2: PFS with second-line alpelisib + fulvestrant vs everolimus + exemestane in postmenopausal pts with PIK3CA-mut hormone-receptor positive (HR+) human epidermal growth factor receptor-2 negative (HER2-) advanced breast cancer (ABC)

Annals of oncology, 2020-05, Vol.31, p.S74-S74

2020

Volltextzugriff (PDF)

Efficacité en vie réelle du voxelotor dans le traitement de la drépanocytose : analyses de groupe et dans les sous-groupes pédiatriques des effets sur les transfusions, les crises vaso-occlusives et les hospitalisations

La revue de medecine interne, 2023-06, Vol.44, p.A177-A178

2023

Volltextzugriff (PDF)

Adherence with inhaled corticosteroids in asthma patients receiving fluticasone propionate/salmeterol in a single inhaler versus add-on salmeterol inhaler or add-on montelukast

Journal of allergy and clinical immunology, 2005-02, Vol.115 (2), p.S1-S1

2005

Volltextzugriff (PDF)

330P Comparative effectiveness of ribociclib plus fulvestrant (RIB+FUL) versus palbociclib plus letrozole (PAL+LET) as first-line (1L) treatment (Tx) of HR+/HER2− advanced breast cancer (ABC) assessed by matching-adjusted indirect comparison (MAIC)

Annals of oncology, 2020-09, Vol.31, p.S377-S378

2020

Volltextzugriff (PDF)

7124 Association between time to disease progression (TDP) endpoints and overall survival (OS) in patients with metastatic renal cell carcinoma (mRCC)

European journal of cancer supplements, 2009, Vol.7 (2), p.430-430

2009

Volltextzugriff (PDF)

142P Quality-adjusted survival with ribociclib plus fulvestrant (R+F) versus placebo plus fulvestrant (P+F) in postmenopausal women (PMW) HR+/HER2- advanced breast cancer (ABC) based on the MONALEESA-3 trial

Annals of oncology, 2020-05, Vol.31, p.S66-S66

2020

Volltextzugriff (PDF)

Expérience en vie réelle du voxelotor dans la prise en charge des complications de la drépanocytose

La revue de medecine interne, 2022-06, Vol.43, p.A201-A201

2022

Volltextzugriff (PDF)

Taux d’hémoglobine et complications chez les patients drépanocytaires – analyse à partir d’une large base de données de santé

La revue de medecine interne, 2022-06, Vol.43, p.A202-A203

2022

Volltextzugriff (PDF)

Understanding electric power systems: an overview of the technology, the marketplace, and government regulation

2nd Edition, 2010

Volltextzugriff (PDF)

RWD87 Real-World Treatment Patterns, Healthcare Costs, and Healthcare Resource Utilization in Patients in the US With Metastatic Non-Small Cell Lung Cancer Receiving Systemic Anticancer Therapy

Value in health, 2024-06, Vol.27 (6), p.S374-S374

2024

Volltextzugriff (PDF)

Health resource utilization (HRU) and cost associated with bone metastases (BMets) and skeletal related events (SREs) in patients (Pts) with prostate cancer (PC)

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.e16542-e16542

2011

Volltextzugriff (PDF)

1 – 25 von 586

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(383)
Mit Volltextzugriff
(491)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(184)
Life Sciences & Biomedicine
(166)
Humans
(150)
Female
(88)
Male
(82)
Middle Aged
(63)
Adult
(56)
Aged
(39)
Biological And Medical Sciences
(29)
Health Care Sciences & Services
(28)
Oncology
(28)
Medical Sciences
(27)
Public Health
(27)
Cost-Benefit Analysis
(26)
General & Internal Medicine
(26)
Medicine, General & Internal
(26)
Adolescent
(25)
Retrospective Studies
(24)
Electronics & Communications Engineering
(23)
Internal Medicine
(23)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

EZB Electronic Journals Library
(268)
IngentaConnect
(187)
Journals@Ovid Ovid Full Text
(184)
MEDLINE
(164)
NUS Single-Journal Subscriptions
(124)
Elsevier ScienceDirect Journals Complete
(106)
Ebook Central Perpetual and DDA
(86)
eBooks on EBSCOhost
(84)
Wiley Online Library
(68)
Wiley Online Library All Obooks
(59)
IngentaConnect Journals
(55)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(30)
SpringerLink_现刊
(29)
JSTOR
(24)
Taylor & Francis
(21)
Taylor & Francis Online
(20)
Taylor & Francis Journals
(20)
Wiley Online Library
(16)
Oxford Journals
(14)
Oxford Journals 2020 Medicine
(13)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Preferences of Canadian patients and physicians for adjuvant treatments for melanoma

Cost-effectiveness of pazopanib compared with sunitinib in metastatic renal cell carcinoma in Canada

Healthcare utilization and costs associated with skeletal-related events in prostate cancer patients with bone metastases

Association between treatment effects on disease progression end points and overall survival in clinical studies of patients with metastatic renal cell carcinoma

Cost-effectiveness of lapatinib plus letrozole in her2-positive, hormone receptor-positive metastatic breast cancer in Canada

The Cost of Treatment of Skeletal-Related Events in Patients with Bone Metastases from Lung Cancer

Cost-effectiveness of pazopanib in advanced soft-tissue sarcoma in Canada

1353P Prediction of the risk of recurrence in patients with non-small cell lung cancer using an integrated claims and electronic medical record database

Cost-effectiveness of zoledronic acid compared with clodronate in multiple myeloma

Conclusions regarding relative cost–utility of alternative strategies for use of aromatase inhibitors in postmenopausal women with early breast cancer are premature

The Causal Role for Genital Ulcer Disease as a Risk Factor for Transmission of Human Immunodeficiency Virus: An Application of the Bradford Hill Criteria

Cost effectiveness of carvedilol for heart failure

POSC34 Comparative Efficacy and Safety of Isatuximab Plus Pomalidomide and Dexamethasone Versus Daratumumab Plus Pomalidomide and Dexamethasone in Patients with Multiple Myeloma Using a Matching-Adjusted Indirect Comparison

2.212 Improved adherence to levodopa/carbidopa/entacapone (Stalevo®) or levodopa/carbidopa and entacapone as separate tablets reduces medical care utilization and costs among Parkinson's disease patients

163P Population-adjusted comparison of SOLAR-1 and BOLERO-2: PFS with second-line alpelisib + fulvestrant vs everolimus + exemestane in postmenopausal pts with PIK3CA-mut hormone-receptor positive (HR+) human epidermal growth factor receptor-2 negative (HER2-) advanced breast cancer (ABC)

Efficacité en vie réelle du voxelotor dans le traitement de la drépanocytose : analyses de groupe et dans les sous-groupes pédiatriques des effets sur les transfusions, les crises vaso-occlusives et les hospitalisations

Adherence with inhaled corticosteroids in asthma patients receiving fluticasone propionate/salmeterol in a single inhaler versus add-on salmeterol inhaler or add-on montelukast

330P Comparative effectiveness of ribociclib plus fulvestrant (RIB+FUL) versus palbociclib plus letrozole (PAL+LET) as first-line (1L) treatment (Tx) of HR+/HER2− advanced breast cancer (ABC) assessed by matching-adjusted indirect comparison (MAIC)

7124 Association between time to disease progression (TDP) endpoints and overall survival (OS) in patients with metastatic renal cell carcinoma (mRCC)

142P Quality-adjusted survival with ribociclib plus fulvestrant (R+F) versus placebo plus fulvestrant (P+F) in postmenopausal women (PMW) HR+/HER2- advanced breast cancer (ABC) based on the MONALEESA-3 trial

Expérience en vie réelle du voxelotor dans la prise en charge des complications de la drépanocytose

Taux d’hémoglobine et complications chez les patients drépanocytaires – analyse à partir d’une large base de données de santé

Understanding electric power systems: an overview of the technology, the marketplace, and government regulation

RWD87 Real-World Treatment Patterns, Healthcare Costs, and Healthcare Resource Utilization in Patients in the US With Metastatic Non-Small Cell Lung Cancer Receiving Systemic Anticancer Therapy

Health resource utilization (HRU) and cost associated with bone metastases (BMets) and skeletal related events (SREs) in patients (Pts) with prostate cancer (PC)

Suchergebnisse filtern